VaccImmune ApS: Financial statements 2020
CVR: 39434520
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
VaccImmune ApS (CVR 39434520) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 22,188 and a net result of DKK 22,188 compared with DKK -11,706 the year before. Equity in the 2020 report amounted to DKK 1. The solvency ratio was 0%.
- Gross Profit
- DKK 22,188
- Profit/Loss
- DKK 22,188
- Equity
- DKK 1
- Total Assets
- DKK 19,100
- Employees
- 0
Official annual report
How creditworthy is VaccImmune ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of September 8, 2020, Anders Rubinstein is registered as liquidator of VaccImmune ApS.
As of September 8, 2020, Morten Albrechtsen has stepped down as adm. dir. of VaccImmune ApS.
On September 8, 2020, VaccImmune ApS entered liquidation.
VaccImmune ApS has published its annual report for 2019. The net result was DKK -11,706.
About VaccImmune ApS
VaccImmune ApS was a Danish company of the type Anpartsselskab based in Nivå, founded in 2018. The company has been dissolved on 17 November 2021. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named VaccImmune IVS and Locimune IVS. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a gross profit of DKK 22,188 and a net result of DKK 22,188 compared with DKK -11,706 the year before. Equity in the 2020 report amounted to DKK 1.